Toronto-based Pentavere wins Prix Galien

TORONTO – HEALWELL AI Inc., a healthcare technology company focused on AI and data science for preventative care, is pleased to announce that its subsidiary, Pentavere Research Group, has been awarded the Prix Galien USA 2024 prize in the Best Startup category for Digital Health and Medical Technology.

Pentavere’s DARWEN AI platform was awarded for its proven contribution in making healthcare more accessible and personalized for patients. Pentavere was selected as one of two recipients from a total of 43 nominees in the Best Startup category.

Aaron Leibtag (pictured), CEO and co-founder of Pentavere, commented, “We are honoured to receive this prestigious award from The Galien Foundation in recognition of our best-in-class DARWEN AI platform for the impact it is having for providers and patients. At Pentavere, we envision that using AI to fully understand the entire patient journey at scale could be as transformative as decoding the human genome.”

He added, “Receiving a Prix Galien award by a panel of some of the most respected global thought leaders from across the life science industry validated the enormity of our AI work to improve the human condition.”

The Prix Galien Award is among the global health innovation industry’s most renowned honours, recognizing outstanding biomedical and medical technology product achievements that improve the human condition.

The award was presented during a ceremony at the American Museum of Natural History in New York on Thursday, November 7, 2024. This was the first win for Pentavere after three nominations in previous years.

The Galien Foundation oversees and directs activities in the US for the Prix Galien, an international awards program dedicated to recognizing and honouring progress through innovative medicines development, with chapters in 15 countries.

During a speech in 2008, former President Bill Clinton referred to the Prix Galien award as “equivalent to the Nobel Prize” in life sciences. The Prix Galien USA is considered America’s preeminent prize acknowledging the leading-edge of scientific advances in the life sciences industry since 2007.

For more information: https://www.galienfoundation.org/prix-galien-usa.